Valproate in Dementia (VALID)

PHASE3CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2009

Study Completion Date

December 31, 2009

Conditions
Alzheimer Disease
Interventions
DRUG

Valproate

250mg tablets beginning with one daily for one week, then two daily for one week, then titrated according to body weight and tolerability to achieve 10-12 mg/kg daily for 2 years, followed by a 2-month washout

DRUG

Placebo

Placebo tablets beginning with one daily and increasing according to weight and perceived tolerability concerns for two years, followed by a 2-month washout

Trial Locations (46)

10016

New York University Medical Center, New York

10032

Columbia University, New York

12208

Albany Medical Center, Albany

13210

Syracuse VA Medical Center, Syracuse

14226

Dent Neurologic Institute, Amherst

14642

University of Rochester, Rochester

14760

Global Research and Consulting, Olean

20057

Georgetown University Medical Center, Washington D.C.

20060

Howard University, Washington D.C.

22908

University of Virginia, Charlottesville

29203

Medical University of South Carolina-Columbia, Columbia

29502

Medical University of South Carolina-Florence, Florence

30329

Emory University, Atlanta

32103

Pacific Research Network, San Diego

32224

Mayo Clinic, Jacksonville

33140

Wein Center, Mount Sinai Medical Center, Miami

33407

Premier Research Institute, West Palm Beach

33617

University of South Florida, Tampa

33647

Byrd Institute, Tampa

37203

Psychiatric Consultants, Nashville

44120

Case Western Reserve University, University Hospitals of Cleveland, Cleveland

44122

North East Ohio Health Services, Beachwood

49503

Saint Mary's Health Care, Grand Rapids

60611

Northwestern University, Chicago

62794

Southern Illinois University, Springfield

63103

St. Louis University, St Louis

66160

University of Kansas, Kansas City

85351

Sun Health Research Institute, Sun City

85724

University of Arizona, Tucson

90095

University of California, LA (Olive View), Los Angeles

90822

VA Healthcare System Long Beach, Long Beach

94304

Stanford University, VA Aging Clinical Research Center, Stanford

92697-4540

University of California, Irvine, Irvine

92093-0624

University of California, ADRC, San Diego, La Jolla

90089-0191

University of Southern California, Los Angeles

90095-1769

University of California ADRC, Los Angeles

06511

Yale University School of Medicine, New Haven

46202-5120

Indiana University School of Medicine, Indianapolis

01805

Lahey Clinic, Research Neurology, Burlington

48109-0489

University of Michigan, Ann Arbor

89154-5084

University of Nevada, Las Vegas

19104-4283

University of Pennsylvania, Philadelphia

02860

Brown University, Memorial Hospital of Rhode Island, Providence

29406-6076

Medical University of South Carolina, North Charleston

75390-9070

University of Texas Southwestern Medical Center, Dallas

05201

Southwestern Vermont Medical Center, Bennington

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Alzheimer's Disease Cooperative Study (ADCS)

OTHER

NCT00071721 - Valproate in Dementia (VALID) | Biotech Hunter | Biotech Hunter